fazarabine has been researched along with Adenocarcinoma, Basal Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blessing, JA; Look, KY; Manetta, A | 1 |
| Ben-Baruch, N; Cowan, KH; Denicoff, AM; Goldspiel, BR; O'Shaughnessy, JA | 1 |
| Casper, ES; Kelsen, DP; Schwartz, GK | 1 |
3 trial(s) available for fazarabine and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
A phase II study of fazarabine in patients with advanced ovarian cancer. A Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Antineoplastic Agents; Azacitidine; Female; Humans; Infusions, Intravenous; Neoplasm Recurrence, Local; Ovarian Neoplasms; Treatment Outcome | 1995 |
Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Azacitidine; Colonic Neoplasms; Drugs, Investigational; Female; Humans; Infusions, Intravenous; Male; Middle Aged | 1993 |
Phase II trial of fazarabine (arabinofuranosyl-5-azacytidine) in patients with advanced pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Azacitidine; Female; Humans; Infusion Pumps; Male; Middle Aged; Pancreatic Neoplasms | 1992 |